John Alvarez

2.1k total citations
25 papers, 1.4k citations indexed

About

John Alvarez is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, John Alvarez has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in John Alvarez's work include Circadian rhythm and melatonin (5 papers), Immunotherapy and Immune Responses (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). John Alvarez is often cited by papers focused on Circadian rhythm and melatonin (5 papers), Immunotherapy and Immune Responses (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). John Alvarez collaborates with scholars based in United States, Belgium and Australia. John Alvarez's co-authors include Amita Sehgal, Dennis Y. Loh, Hiroyuki Niida, Tadashi Joh, Terumi Kohwi-shigematsu, Dag H. Yasui, Dechun Chen, Piotr Bębas, Teri Ord and Carmen J. Williams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

John Alvarez

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Alvarez United States 15 499 426 332 266 227 25 1.4k
Guiomar Solanas Spain 15 827 1.7× 401 0.9× 110 0.3× 190 0.7× 365 1.6× 18 1.6k
Hamid Dolatshad United Kingdom 16 549 1.1× 260 0.6× 106 0.3× 103 0.4× 150 0.7× 25 1.0k
Holger Kissel United States 13 830 1.7× 101 0.2× 369 1.1× 176 0.7× 127 0.6× 13 1.5k
Teresa M. McShane United States 20 269 0.5× 277 0.7× 70 0.2× 153 0.6× 157 0.7× 27 1.3k
Daisuke Yamada Japan 22 1.4k 2.8× 163 0.4× 278 0.8× 556 2.1× 181 0.8× 65 2.2k
Ryosuke Tsunematsu Japan 15 1.6k 3.2× 189 0.4× 134 0.4× 731 2.7× 83 0.4× 26 2.1k
Dena S. Leeman United States 11 1.2k 2.4× 61 0.1× 220 0.7× 178 0.7× 234 1.0× 15 2.0k
B. Morse United States 11 1.1k 2.2× 116 0.3× 271 0.8× 137 0.5× 123 0.5× 13 1.5k
Zhaohai Yang United States 25 850 1.7× 494 1.2× 81 0.2× 1.1k 4.3× 103 0.5× 78 2.9k
Seiya Mizuno Japan 20 755 1.5× 84 0.2× 165 0.5× 232 0.9× 97 0.4× 101 1.4k

Countries citing papers authored by John Alvarez

Since Specialization
Citations

This map shows the geographic impact of John Alvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Alvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Alvarez more than expected).

Fields of papers citing papers by John Alvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Alvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Alvarez. The network helps show where John Alvarez may publish in the future.

Co-authorship network of co-authors of John Alvarez

This figure shows the co-authorship network connecting the top 25 collaborators of John Alvarez. A scholar is included among the top collaborators of John Alvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Alvarez. John Alvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodkinson, Brendan P., Michael Schäffer, Joshua Brody, et al.. (2020). Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation. Translational Oncology. 14(1). 100977–100977. 14 indexed citations
2.
Hodkinson, Brendan P., Michael Schäffer, Joshua Brody, et al.. (2019). Abstract 4024: Phase 1/2a LYM1002 study of ibrutinib (ibr) + nivolumab (nivo): Exome and gene expression profiling (GEP) analyses by histology and responder status. Cancer Research. 79(13_Supplement). 4024–4024. 1 indexed citations
3.
Cole, Suzanne, Alice M. Walsh, Xuefeng Yin, et al.. (2018). Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research & Therapy. 20(1). 85–85. 85 indexed citations
4.
Menard, Krista, Emily Chen, Kristen Chevalier, et al.. (2018). Abstract A11: Preclinical assessment of CD3 bispecific antibody efficacy: A comparison of humanized mouse models bearing xenografts and syngeneic mouse models using surrogate antibodies. Cancer Research. 78(10_Supplement). A11–A11. 1 indexed citations
5.
Musk, Arthur W., John Alvarez, Cyril Mamotte, et al.. (2018). Elderly dendritic cells respond to LPS/IFN-γ and CD40L stimulation despite incomplete maturation. PLoS ONE. 13(4). e0195313–e0195313. 15 indexed citations
6.
Karkera, Jayaprakash D., Dana Gaffney, Ademi Santiago-Walker, et al.. (2017). Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib. Molecular Cancer Therapeutics. 16(8). 1717–1726. 43 indexed citations
7.
Álvarez, Sara, Josette William, Debra Hanks, et al.. (2017). Development of a clinical trial immunohistochemistry (IHC) assay using a novel antibody to CD38.. Journal of Clinical Oncology. 35(15_suppl). 7561–7561. 1 indexed citations
8.
Masucci, Giuseppe, Alessandra Cesano, Rachael E. Hawtin, et al.. (2016). Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation. Journal for ImmunoTherapy of Cancer. 4(1). 76–76. 142 indexed citations
9.
Dobbin, Kevin K., Alessandra Cesano, John Alvarez, et al.. (2016). Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerations. Journal for ImmunoTherapy of Cancer. 4(1). 77–77. 78 indexed citations
10.
Sasser, Kate, Tineke Casneuf, Amy Axel, et al.. (2016). Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. Breast Cancer Targets and Therapy. 8. 13–13. 20 indexed citations
11.
Wikström, Matthew E., et al.. (2015). Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes. OncoImmunology. 5(2). e1082028–e1082028. 23 indexed citations
12.
13.
Alvarez, John, Amanda G. Hansen, Teri Ord, et al.. (2008). The Circadian Clock Protein BMAL1 Is Necessary for Fertility and Proper Testosterone Production in Mice. Journal of Biological Rhythms. 23(1). 26–36. 230 indexed citations
14.
Zheng, Xiangzhong, Zhaohai Yang, Zhifeng Yue, John Alvarez, & Amita Sehgal. (2007). FOXO and insulin signaling regulate sensitivity of the circadian clock to oxidative stress. Proceedings of the National Academy of Sciences. 104(40). 15899–15904. 100 indexed citations
15.
Riggs, James E., et al.. (2004). Mls presentation by peritoneal cavity B cells. Immunobiology. 209(3). 255–264. 8 indexed citations
16.
Alvarez, John, et al.. (2003). Non-cyclic and Developmental Stage-Specific Expression of Circadian Clock Proteins During Murine Spermatogenesis1. Biology of Reproduction. 69(1). 81–91. 118 indexed citations
17.
Alvarez, John & Amita Sehgal. (2002). REV-ving Up the Clock. Developmental Cell. 3(2). 150–152. 4 indexed citations
18.
Alvarez, John, Dag H. Yasui, Hiroyuki Niida, et al.. (2000). The MAR-binding protein SATB1 orchestrates temporal and spatial expression of multiple genes during T-cell development. Genes & Development. 14(5). 521–535. 318 indexed citations
19.
Alvarez, John, Sarah Anderson, & Dennis Y. Loh. (1995). V(D)J recombination and allelic exclusion of a TCR β-chain minilocus occurs in the absence of a functional promoter. The Journal of Immunology. 155(3). 1191–1202. 34 indexed citations
20.
Donoghue, Maria J., John Alvarez, John P. Merlie, & JR Sanes. (1991). Fiber type- and position-dependent expression of a myosin light chain-CAT transgene detected with a novel histochemical stain for CAT.. The Journal of Cell Biology. 115(2). 423–434. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guiomar Solanas Breakdown of academic impact, for papers by Hamid Dolatshad Breakdown of academic impact, for papers by Holger Kissel Breakdown of academic impact, for papers by Teresa M. McShane Breakdown of academic impact, for papers by Daisuke Yamada Breakdown of academic impact, for papers by Ryosuke Tsunematsu Breakdown of academic impact, for papers by Dena S. Leeman Breakdown of academic impact, for papers by B. Morse Breakdown of academic impact, for papers by Zhaohai Yang Breakdown of academic impact, for papers by Seiya Mizuno
Rankless by CCL
2026